Protein disulfide isomerase modification and inhibition contribute to ER stress and apoptosis induced by oxidized low density lipoproteins

Antioxidants and Redox Signaling

Volumn 18, Issue 7, 2013, Pages 731-742

  Muller, Carole ^a,b   Bandemer, Jan ^a   Vindis, Cecile ^a,b   Camaré, Caroline ^a,b   Mucher, Elodie ^b   Guéraud, Françoise ^c   Larroque Cardoso, Pauline ^a,b   Bernis, Corinne ^a,b   Auge, Nathalie ^a,b   Salvayre, Robert ^a,b   Negre Salvayre, Anne ^a,b  

^a University Hospital of Toulouse   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BACITRACIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN DISULFIDE ISOMERASE; PYRIDOXAMINE;

APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INCUBATION TIME; LIPID PEROXIDATION; MACROPHAGE; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; WILD TYPE;

APOPTOSIS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN DISULFIDE-ISOMERASES; STRUCTURE-ACTIVITY RELATIONSHIP; U937 CELLS;

EID: 84872978155     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4577     Document Type: Article

References (49)

1. Bouguerne B, Belkheiri N, Bedos-Belval F, Vindis C, Uchida K, Duran H, Grazide MH, Baltas M, Salvayre R, and Nègre-Salvayre A. Antiatherogenic effect of bisvanillyl-hydralazone, a new hydralazine derivative with antioxidant, carbonyl scavenger, and antiapoptotic properties. Antioxid Redox Signal 14: 2093-2106, 2011.
2. Carbone DL, Doorn JA, Kiebler Z, and Petersen DR. Cy-steine modification by lipid peroxidation products inhibits protein disulfide isomerase. Chem Res Toxicol 18:1324-1331, 2005.
3. Creighton TE, Hillson DA, and Freedman RB. Catalysis by protein-disulphide isomerase of the unfolding and refolding of proteins with disulphide bonds. J Mol Biol 142: 43-62, 1980.
4. Escargueil-Blanc I, Salvayre R, Vacaresse N, Jürgens G, Darblade B, Arnal JF, Parthasarathy S, and Nègre-Salvayre A. Mildly oxidized LDL induces activation of platelet-derived growth factor beta-receptor pathway. Circulation 104:1814-1821, 2001.
5. Esterbauer H, Gebicki J, Puhl H, and Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13:341-390, 1992.
6. Guéraud F, Atalay M, Bresgen N, Cipak A, Eckl PM, Huc L, Jouanin I, Siems W, and Uchida K. Chemistry and biochemistry of lipid peroxidation products. Free Radic Res 44: 1098-1124, 2010.
7. Hoffstrom BG, Kaplan A, Letso R, Schmid RS, Turmel GJ, Lo DC, and Stockwell BR. Inhibitors of protein disulfide isom-erase suppress apoptosis induced by misfolded proteins. Nat Chem Biol 12: 900-906, 2010.
8. Hotamisligil GS. Endoplasmic reticulum stress and atherosclerosis. Nat Med 16: 396-399, 2010.
9. Kozlov G, Määttänen P, Thomas DY, and Gehring K. A structural overview of the PDI family of proteins. FEBS J 277: 3924-3936, 2010.
10. Libby P, Ridker PM, and Maseri A. Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.
11. Lusis AJ. Atherosclerosis. Nature 407: 233-241, 2000.
12. Lovat PE, Corazzari M, Armstrong JL, Martin S, Pagliarini V, Hill D, Brown AM, Piacentini M, Birch-Machin MA, and Redfern CP. Increasing melanoma cell death using inhibitors of protein disulfide isomerase to abrogate survival responses to endoplasmic reticulum stress. Cancer Res 68: 5363-5369, 2008.
13. Mandel R, Ryser HJ, Ghani F, Wu M, and Peak D. Inhibition of a reductive function of the plasma membrane by baci-tracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci USA 90: 4112-4116, 1993.
14. Myoishi M, Hao H, Minamino T, Watanabe K, Nishihira K, Hatakeyama K, Asada Y, Okada K, Ishibashi-Ueda H, Gabbiani G, Bochaton-Piallat ML, Mochizuki N, and Kitakaze M. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation 116:1226-1233, 2007.
15. Na KS, Park BC, Jang M, Cho S, Leedo H, Kang S, Lee CK, Bae KH, and Park SG. Protein disulfide isomerase is cleaved by caspase-3 and-7 during apoptosis. Mol Cell 24: 261-267, 2007.
16. Napoli C. Oxidation of LDL, atherogenesis, and apoptosis. Ann NY Acad Sci 1010: 698-709, 2003.
17. Negre-Salvayre A, Vieira O, Escargueil-Blanc I, and Sal-vayre R. Oxidized LDL and 4-hydroxynonenal modulate tyrosine kinase receptor activity. Mol Aspects Med 24: 251-261, 2003.
18. Negre-Salvayre A, Coatrieux C, Ingueneau C, and Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol 153: 6-20, 2008.
19. Rabek JP, Boylston WH 3rd, and Papaconstantinou J. Car-bonylation of ER chaperone proteins in aged mouse liver. Biochem Biophys Res Commun 305: 566-572, 2003.
20. Raturi A and Mutus B. Characterization of redox state and reductase activity of protein disulfide isomerase under different redox environments using a sensitive fluorescent assay. Free Radic Biol Med 43: 62-70, 2007.
21. Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, and Thorpe SR. Lipoxidation products as biomarkers of oxida-tive damage to proteins during lipid peroxidation reactions. Nephrol Dial Transplant 11 Suppl 5: 48-53, 1996.
22. Riemer J, Bulleid N, and Herrmann JM. Disulfide formation in the ER and mitochondria: tTwo solutions to a common process. Science 324: 1284-1287, 2009.
23. Riahi Y, Cohen G, Shamni O, and Sasson S. Signaling and cytotoxic functions of 4-hydroxyalkenals. Am J Physiol En-docrinol Metab 299: E879-886, 2010.
24. Ron D and Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8: 519-529, 2007.
25. Sanson M, Ingueneau C, Vindis C, Thiers JC, Glock Y, Rousseau H, Sawa Y, Bando Y, Mallat Z, Salvayre R, and Nègre-Salvayre A. Oxygen-regulated protein-150 prevents calcium homeostasis deregulation and apoptosis induced by oxidized LDLs in vascular cells. Cell Death Differ 15: 1255-1265, 2008.
26. Sanson M, Augé N, Vindis C, Muller C, Bando Y, Thiers JC, Marachet MA, Zarkovic K, Sawa Y, Salvayre R, and Nègre-Salvayre A. Oxidized LDLs trigger endoplasmic reticulum stress in vascular cells: Prevention by oxygen-regulated protein 150 expression. Circ Res 104: 328-336, 2009.
27. Santos CX, Tanaka LY, Wosniak J, and Laurindo FR. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: Roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal 11: 2409-2427, 2009.
28. Schmitt A, Salvayre R, Delchambre J, and Nègre-Salvayre A. Prevention by alpha-tocopherol and rutin of glutathione and ATP depletion induced by oxidized LDL in cultured endo-thelial cells. Br J Pharmacol 116: 1985-1990, 1995.
29. Smathers RL, Galligan JJ, Stewart BJ, and Petersen DR. Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chem Biol Interact 192: 107-112, 2011.
30. Song B, Scheuner D, Ron D, Pennathur S, and Kaufman RJ. CHOP deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J Clin Invest 118: 3378-3389, 2008.
31. Tabas I. The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ Res 107: 839-850, 2010.
32. Tanaka S, Uehara T, and Nomura Y. Up-regulation of pro-tein-disulfide isomerase in response to hypoxia/brain ischemia and its protective effect against apoptotic cell death. J Biol Chem 275: 10388-10393, 2000.
33. Thorp E, Li G, Seimon TA, Kuriakose G, Ron D, and Tabas I. Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of ApoE-/-and LDLr-/-mice lacking CHOP. Cell Metab 9: 474-481, 2009.
34. Toldo S, Severino A, Abbate A, and Baldi A. The role of PDI as a survival factor in cardiomyocyte ischemia. Methods Enzymol 489: 47-65, 2011.
35. Townsend DM, Manevich Y, He L, Xiong Y, Bowers RR Jr, Hutchens S, and Tew KD. Nitrosative stress-induced S-glu-tathionylation of protein disulfide isomerase leads to activation of the unfolded protein response. Cancer Res 69: 7626-7634, 2009.
36. Tsimikas S and Miller YI. Oxidative modification of lipo-proteins: Mechanisms, role in inflammation and potential clinical applications in cardiovascular disease. Curr Pharm Des 17: 27-37, 2011.
37. Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Radic Biol Med 28: 1685-1696, 2000.
38. Uchida K. Lipid peroxidation and redox-sensitive signaling pathways. Curr Atheroscler Rep 9: 216-221, 2007.
39. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441: 513-517, 2006.
40. Vieira O, Escargueil-Blanc I, Jürgens G, Borner C, Almeida L, Salvayre R, and Nègre-Salvayre A. Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis. FASEB J 14: 532-542, 2000.
41. Vindis C, Elbaz M, Escargueil-Blanc I, Augé N, Heniquez A, Thiers JC, Nègre-Salvayre A, and Salvayre R. Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced apoptosis. Arterioscler Thromb Vasc Biol 25: 639-645, 2005.
42. Walker KW and Gilbert HF. Scanning and escape during protein-disulfide isomerase-assisted protein folding. J Biol Chem 272: 8845-8848, 1997.
43. Wang M, Ye R, Barron E, Baumeister P, Mao C, Luo S, Fu Y, Luo B, Dubeau L, Hinton DR, and Lee AS. Essential role of the unfolded protein response regulator GRP78/BiP in protection from neuronal apoptosis. Cell Death Differ 17: 488-7498, 2010.
44. Weissman JS and Kim PS. Efficient catalysis of disulphide bond rearrangements by protein disulfide isomerase. Nature 365: 185-188, 1993.
45. Wilkinson B and Gilbert HF. Protein disulfide isomerase. Biochim Biophys Acta 1699: 35-44, 2004.
46. Witztum JL and Steinberg D. Role of oxidized LDL in ath-erogenesis. J Clin Invest 88: 1785-1792, 1991.
47. Wu J and Kaufman RJ. From acute ER stress to physiological roles of the Unfolded Protein Response. Cell Death Differ 13: 374-384, 2006.
48. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, and Steinberg D. Evidence for the presence of oxidatively modified LDL in atherosclerotic lesions of rabbit and man. J Clin Invest 84: 1086-1095, 1989.
49. Zhou J, Lhoták S, Hilditch BA, and Austin RC. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 111: 18141-1821, 2005.